Replay available

TRxADE HEALTH, Inc. (MEDS) Q2 2022 Earnings Call

TRxADE HEALTH, Inc. (NASDAQ: MEDS) Q2 2022 earnings conference call, held 2022-07-25. Replay captured from the company's public earnings webcast.

Mon, July 25, 2022 at 5:00 PMendedReplay
TRxADE HEALTH, Inc. (MEDS) Q2 2022 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Surin Ajayrapu

Founder, Chairman & Chief Executive Officer

Janet Huffman

Chief Financial Officer

Alan Klee

Analyst, Maxim Group

Howard Halpert

Analyst, AgriBrothers

Replay transcript excerpt

Good afternoon, ladies and gentlemen. Thank you for standing by. Welcome to TraxAid Health's second quarter 2022 earnings conference call. During today's presentation, all parties will be in a listen-only mode. Following the presentation, the conference will be open for questions. The earnings press release accompanying this conference call was issued at the close of the market today. The quarterly report, which includes additional information regarding the company's results of the operations for the quarter ended June 30, 2022, was filed with the SEC earlier today. On our call today is TraxAid Health's founder, chairman, and chief executive officer, Surin Ajayrapu, and Janet Huffman, its chief financial officer. The replay of this call and webcast will be available for the next 30 days on the company's website under the NASDAQ Meds link. The company's website also includes more supporting industry information. At this time, I'd like to turn the call over to Janet Huffman, the company's chief financial officer. Janet, the floor is yours. Thank you, operator, and thank you for joining us today. I'd like to welcome you to our 2022 second quarter financial results conference call. A press release announcing our 2022 second quarter financial results was issued after the close of market today and is posted on our website. We have also furnished such press release to the SEC on form 8K. Statements made on this call and webcast will include forward-looking statements. These statements include, but are not limited to, our outlook for the company and statements that estimate or project future results of operations or the performance of the company. These statements speak only as of the date hereof, and the company assumes no obligation, except as required by law, to revise an...

More from Scienture Holdings, Inc.